ARVN · Arvinas, Inc.

Summary

Arvinas, Inc. announced that John Houston, Ph.D. resigned as President, CEO, and Chair of the Board effective February 12, 2026, transitioning to a director and consultant role. The Board appointed Randy Teel, Ph.D. as new President, CEO, and Board member, and Briggs Morrison, M.D. as new Board Chair, effective the same date.

Key takeaways

• John Houston, Ph.D. resigned as President, CEO, and Board Chair effective 2026-02-12, remaining as director and consultant until 2027-03-01.
• Randy Teel, Ph.D. appointed President, CEO, principal executive officer, and Board member effective 2026-02-12.
• Briggs Morrison, M.D. appointed Board Chair effective 2026-02-12.
• Dr. Teel's employment agreement: base salary $680,000, 60% target bonus, option for 218,691 shares, RSU for 147,179 shares.
• Dr. Houston consulting: $27,914.40 COBRA lump sum, $457,000 bonus equivalent, continued equity vesting.